Page Analysis
Related Links:
acadia-pharm.com
Acadia Pharmaceuticals
Identifies target-specific small molecule drug candidates using a proprietary chemical-genomics platform. Description of technology, investor relations, careers, and contacts.
Identifies target-specific small molecule drug candidates using a proprietary chemical-genomics platform. Description of technology, investor relations, careers, and contacts.
http://www.acadia-pharm.com/
Daily Ad Revenue: ~n/a
Estimated Revenue: ~n/a
Links: 70
Speed: ( seconds) % of sites are slower.
Online Since: Aug 14, 1997

Web page information
- Keywords hit in search results 92121 acadia access accessed
accessibleagainst agonist announceannualarchived being biovail cautionary common companies company conference daily developed developmentprograms dialing diegodilutededucational event exposed financial first fourth future hoover information inverse investors maintains million needhamobligationparkinsonparticipants penny pharm pharmaceuticals phase pimavanserin posts premiumpresentpresentation profile program quarter receptor regularly reported reports resultsrevisesecond sectionsharestatementstock study subscription tablet third treatment underundertakesupdate visit webcast website which - Search Engine Recommended Keywords

Web Traffic

Web Graph


Web Results
ACADIA Pharmaceuticals to Present at the 11th Annual Needham ...
ACADIA maintains a website at www.acadia-pharm.com to which ACADIA regularly posts ... statement and ACADIA undertakes no obligation to revise or update ...
... HT 2A receptor inverse agonist being developed by Acadia and Biovail as a once-daily oral tablet. For more information call (858) 558-2871 or visit www.acadia-pharm.com.
... accessed by dialing 866-202-3109 for participants in the U.S. or ... call also will be webcast live on ACADIA’s website, www.acadia-pharm.com ...
... webcast of the event will be accessible on the company's website, www.acadia-pharm.com ... cautionary statement and ACADIA undertakes no obligation to revise or ...
... may be accessed by dialing 866-362-4829 for participants in the U.S. or ... conference call also will be webcast live on ACADIA’s website, www.acadia-pharm.com ...
... may be accessed by dialing 866-711-8198 for participants in the U.S. or ... conference call also will be webcast live on ACADIA’s website, www.acadia-pharm.com ...
A live webcast of ACADIA’s presentation will be accessible on the company’s website, www.acadia-pharm.com, under the investors section and an archived ...
ACADIA reported a net loss of $6.6 million, or $0.12 per common share ... The conference call also will be webcast live on ACADIA’s website, www.acadia-pharm.com ...
http://www.acadia-pharm.com: San Diego, CA 92121: Fax: 858-558-2872: Map This Company ... Premium Subscription. Access over 85 million companies Call (866) 443-3939 or
Net loss was $6.218 million or $0.12 per diluted share against $5.833 million or $0.12 per diluted ... financial results and developmentprograms.www.acadia-pharm.com ...
ACADIA maintains a website at www.acadia-pharm.com to which ACADIA regularly posts ... statement and ACADIA undertakes no obligation to revise or update ...
http://finance.yahoo.com/news/acadia-pharmaceuticals-present-11th-annual-130000601.html
Phase 3 study of pimavanserin for the treatment of Parkinson's ...... HT 2A receptor inverse agonist being developed by Acadia and Biovail as a once-daily oral tablet. For more information call (858) 558-2871 or visit www.acadia-pharm.com.
http://www.empr.com/phase-3-study-of-pimavanserin-for-the-treatment-of-parkinsons-disease-psychosis-pdp/article/175826/
ACADIA Pharmaceuticals to Announce First Quarter 2012 Financial ...... accessed by dialing 866-202-3109 for participants in the U.S. or ... call also will be webcast live on ACADIA’s website, www.acadia-pharm.com ...
http://finance.yahoo.com/news/acadia-pharmaceuticals-announce-first-quarter-130000612.html
ACADIA Pharmaceuticals to Webcast Educational Program on Parkinson ...... webcast of the event will be accessible on the company's website, www.acadia-pharm.com ... cautionary statement and ACADIA undertakes no obligation to revise or ...
http://www.marketwatch.com/story/acadia-pharmaceuticals-to-webcast-educational-program-on-parkinsons-disease-psychosis-on-may-22-2012-2012-05-15
ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year ...... may be accessed by dialing 866-362-4829 for participants in the U.S. or ... conference call also will be webcast live on ACADIA’s website, www.acadia-pharm.com ...
http://markets.financialcontent.com/stocks/news/read?GUID=17530406
ACADIA Pharmaceuticals to Announce Third Quarter 2011 Financial ...... may be accessed by dialing 866-711-8198 for participants in the U.S. or ... conference call also will be webcast live on ACADIA’s website, www.acadia-pharm.com ...
http://markets.financialcontent.com/stocks/news/read/19859022/ACADIA_Pharmaceuticals_to_Announce_Third_Quarter_2011_Financial_Results_on_November_9
ACADIA Pharmaceuticals to Present at the 19th Annual Future ...A live webcast of ACADIA’s presentation will be accessible on the company’s website, www.acadia-pharm.com, under the investors section and an archived ...
http://www.biomedreports.com/2012041392783/acadia-pharmaceuticals-to-present-at-the-19th-annual-future-leaders-in-the-biotech-industry-conference-on-april-20-2012.html
ACADIA Pharmaceuticals Reports Second Quarter 2011 Financial ...ACADIA reported a net loss of $6.6 million, or $0.12 per common share ... The conference call also will be webcast live on ACADIA’s website, www.acadia-pharm.com ...
http://www.businesswire.com/news/home/20110810006342/en/ACADIA-Pharmaceuticals-Reports-Quarter-2011-Financial-Results
ACADIA Pharmaceuticals Inc. | Company profile from Hoover's | 858 ...http://www.acadia-pharm.com: San Diego, CA 92121: Fax: 858-558-2872: Map This Company ... Premium Subscription. Access over 85 million companies Call (866) 443-3939 or
http://www.hoovers.com/company/ACADIA_Pharmaceuticals_Inc/rfyfrif-1.html
ACAD ACADIA Pharmaceuticals - Penny Stock ExposedNet loss was $6.218 million or $0.12 per diluted share against $5.833 million or $0.12 per diluted ... financial results and developmentprograms.www.acadia-pharm.com ...
http://www.realpennies.com/otc/ACAD/

Website Rank
| Alexa Rank | Compete Rank / Count | Quantcast Rank | Google PageRank |
|---|---|---|---|
| 2,918,071 | ~ / ~ | ~ |
| Traffic Rank | % of Internet Users | Reach Rank | |
|---|---|---|---|
| Past 1 day: | ~ | ~ | ~ |
| Past 7 days: | 5,481,779 | 0.00002% | 5,238,517 |
| Past 1 month: | 3,388,148 | 0.000029% | 3,660,114 |
| Past 3 months: | 2,918,071 | 0.000036% | 2,946,028 |
| PageViews Rank | % of Internet PageViews | Page Views Per User | |
| Past 1 day: | ~ | ~ | ~ |
| Past 7 days: | 5,550,377 | ~ | 1 |
| Past 1 month: | 3,346,544 | 0.000001% | 2.6 |
| Past 3 months: | 3,243,408 | 0.000001% | 2.3 |
Site Disclaimer:
All trademarks are the property of their respective owners. The facts, figures, reviews, records, stats, and other data presented on this page is for suggestion and information purposes only. SiteGlimpse.com is not responsible for any incorrect or incomplete information. SiteGlimpse.com does not take responsibility for any user-reviews of websites inside its resource and reserves the right to keep or remove those. It is highly recommended that you review all the data for accuracy.
All trademarks are the property of their respective owners. The facts, figures, reviews, records, stats, and other data presented on this page is for suggestion and information purposes only. SiteGlimpse.com is not responsible for any incorrect or incomplete information. SiteGlimpse.com does not take responsibility for any user-reviews of websites inside its resource and reserves the right to keep or remove those. It is highly recommended that you review all the data for accuracy.